Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes
Response to Yoshioka, Yoshida, and Yoshikawa
- Edmond A. Ryan, MD,
- Sharleen Imes, MSC and
- Clarissa Wallace, MD
- From the Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- Address correspondence to Edmond A. Ryan, MD, University of Alberta, 362 Heritage Medical Research Building, Edmonton, Canada T6G 2S2. E-mail: edmond.ryan{at}ualberta.ca
We thank Yoshioka, Yoshida, and Yoshikawa (1) for their interest and comments on our article (2) on the use of a short course of intensive insulin therapy in newly diagnosed type 2 diabetic patients. We are pleased that they think this strategy has merit. Our study was an initial pilot study and did not include detailed measures of insulin sensitivity, and we acknowledge this in the article.
Yoshioka, Yoshida, and Yoshikawa make the point that insulin secretion increased equally …
